Indre Har News Today

WeAreAquaculture spoke to Trond Vadset Veibust, new CFO at Salmon Evolution, about his arrival at the company.

/PRNewswire/ -- Highlights in the quarter: Biomass production is back on track - strong biological performance since mid-May with good appetite and normal...

Salmon Evolution posted lower revenue and wider losses on the heels of an increased mortality event, but also saw its highest ever production.

/PRNewswire/ -- Highlights in the quarter Continued production ramp up at Indre Harøy. Batch 5 stocked in February and all-time high biomass production in...

Reference is made to the stock exchange announcement on 19 April 2023 by Salmon Evolution ASA regarding the successfully placed private placement as described therein and the stock exchange... | May 12, 2023

Reference is made to the stock exchange announcement published by Salmon Evolution ASA on 19 April 2023 regarding the successful placing of a private placement of 68,181,818 shares at a subscription... | May 11, 2023

The share price of Salmon Evolution dropped sharply after it announced it was dealing with a likely outbreak of amoebic gill disease.

Reference is made to the stock exchange announcement published by Salmon Evolution ASA on 19 April 2023 regarding the successful placing of a private placement of 68,181,818 shares at a subscription... | May 9, 2023

Gill health issues “suspected to be caused by external pathogens” have been blamed for increased mortalities at Salmon Evolution’s flagship land-based farm.

Salmon Evolution announced on the Norway-based Oslo Børs stock exchange on April 18 that it is contemplating a private placement of new shares in the company to raise gross proceeds of kr500 million (US$47 million).